Skip to main content
$44.14 $0.38 (0.9%)

04:00 PM EDT on 10/03/22

Pfizer Inc (NYSE:PFE)

CAPS Rating: 3 out of 5

A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra.

Current Price $44.14 Mkt Cap $245.6B
Open $44.07 P/E Ratio 9.83
Prev. Close $44.14 Div. (Yield) $1.60 (3.7%)
Daily Range $43.49 - $44.28 Volume 22,825,792
52-Wk Range $40.94 - $61.71 Avg. Daily Vol. 17,938,537

Caps

How do you think NYSE:PFE will perform against the market?

Add Stock to CAPS Watchlist

All Players

5,614 Outperform
591 Underperform
 

All-Star Players

1,096 Outperform
79 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSE:PFE Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

JohnnyCaffeine (< 20)
Submitted January 13, 2022

Has a solid moat with respect to COVID vaccines, and those will keep going potentially as far as the eye can see as long as the virus is with us. Pfizer also has a very wide range of drugs, a long history, and should do great over time.

TheFoolishAngler (21.18)
Submitted February 06, 2022

Pfizer is a global leader in the bio pharmaceutical space, responsible for many of the most recognizable products on the market including epipen, viagara, Advil and others. Pfizer states their mission “is to become the world's most valued company to… More

Recent Community Commentary

Read the most recent pitches from players about PFE.

Recs

0
Member Avatar MFBriguy (99.97) Submitted: 7/6/2022 1:19:27 PM : Underperform Start Price: $51.81 NYSE:PFE Score: +10.85

The data on C19 efficacy is bad and getting worse. The side effect data is bad and getting worse. The clinical trial data they submitted for emergency use and liabiility protection is littered with inconsistencies and mathematical gymnastics. If their liability protection is revoked, they could break their own record for largest judgement against in history.

Recs

0
Member Avatar raymond2017 (54.06) Submitted: 6/22/2022 10:19:43 AM : Outperform Start Price: $47.68 NYSE:PFE Score: -6.06

P/E of 10 and a dividend of 3.33% at it's present stock price. They also have plenty of cash due to the success of their Covid vaccines.

Recs

0
Member Avatar TMFrdownie (41.12) Submitted: 5/10/2022 6:46:25 PM : Outperform Start Price: $48.29 NYSE:PFE Score: -0.69

Strong pipeline, wide moat, higher-than-average growth among large caps.

Leaderboard

Find the members with the highest scoring picks in PFE.

Score Leader

flickib41

flickib41 (59.75) Score: +179.69

The Score Leader is the player with the highest score across all their picks in PFE.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
compfreak999 78.85 6/20/2008 Outperform 1Y $10.04 +339.58% +187.60% +151.98 1 Comment
SomersGOP < 20 6/23/2008 Outperform 1Y $10.08 +337.81% +186.37% +151.44 0 Comment
DrDrBob 87.24 6/23/2008 7/19/2008 Outperform 3Y $10.08 +337.81% +186.37% +151.44 0 Comment
GracieMD1998 < 20 6/23/2008 Outperform 1Y $10.08 +337.81% +186.37% +151.44 0 Comment
MATTALANKANE 87.77 6/23/2008 Outperform 5Y $10.08 +337.81% +186.37% +151.44 1 Comment
eckertbt < 20 6/23/2008 Outperform 3Y $10.08 +337.81% +186.37% +151.44 1 Comment
mooses2 50.80 6/23/2008 Outperform NS $10.08 +337.81% +186.37% +151.44 0 Comment
gtmitc 30.76 6/23/2008 Outperform 1Y $10.08 +337.81% +186.37% +151.44 0 Comment
AlIskandarani 61.15 6/12/2008 Outperform 1Y $10.20 +332.83% +182.01% +150.82 1 Comment
megamillion2 68.23 6/12/2008 Outperform 5Y $10.20 +332.83% +182.01% +150.82 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for PFE.